What is Othram?
Founded in 2018 and headquartered in The Woodlands, Texas, Othram operates at the intersection of biotechnology and criminal justice. The company specializes in the recovery, enrichment, and analysis of human DNA from samples previously considered too compromised for traditional testing methods. By providing actionable intelligence where conventional forensic approaches fail, Othram has become an essential asset for law enforcement agencies and academic researchers alike. Their proprietary workflow enables the processing of trace quantities of DNA, effectively bridging the gap between complex biological evidence and successful investigative outcomes.
How much funding has Othram raised?
Othram has raised a total of $18.1M across 2 funding rounds:
Debt
$150K
Angel/Seed
$18M
Debt (2020): $150K with participation from PPP
Angel/Seed (2021): $18M led by Gigafund 0
Key Investors in Othram
Gigafund
Gigafund is a venture capital firm that invests in ambitious and transformative entrepreneurs across various sectors and stages. The firm focuses on long-term concentrated investments, seeking founders who can grow with their companies and maximize impact over decades.
PPP
Public-Private Partnership
What's next for Othram?
With this major enterprise-level funding, Othram is well-positioned to scale its laboratory operations and expand its forensic sequencing capabilities. The strategic roadmap likely involves increasing throughput for high-volume case processing and further refining its enrichment protocols to handle increasingly challenging forensic samples. As the company transitions from its initial development phase into a period of rapid operational scaling, it is expected to solidify its dominance in the forensic technology market. Future growth will likely focus on deepening partnerships with public sector entities and enhancing the technological infrastructure required to support the next generation of forensic science applications.
See full Othram company page
